Maggy Donaldson
- Indexed articles, last 90 days
- 4
- Latest publication
- Sep 16, 2026
- Outlet visibility, for Philstar
- Top 50K sites
- Earliest in this view
- Jul 23, 2026
Latest articles
Finneas, other artists exit Ed Sheeran tour in solidarity with Macklemore pro-Palestinian comments (opens the original)
Read excerpt
LOS ANGELES, United States — The artist Finneas and three other supporting acts announced they had quit British superstar Ed Sheeran's tour, after rapper Macklemore was dropped for making pro-Palestinian comments while performing. Sheeran has denied being behind the decision to remove Macklemore, saying his tour's promoter was responsible. But Finneas — a performer also famous for work with his superstar sister Billie Eilish — Irish acts Aaron Rowe and Beoga, and Lukas Graham of Denmark all post
Finneas, other artists exit Ed Sheeran tour in solidarity with Macklemore pro-Palestinian comments (opens the original)
Read excerpt
LOS ANGELES, United States — The artist Finneas and three other supporting acts announced they had quit British superstar Ed Sheeran's tour, after rapper Macklemore was dropped for making pro-Palestinian comments while performing. Sheeran has denied being behind the decision to remove Macklemore, saying his tour's promoter was responsible. But Finneas — a performer also famous for work with his superstar sister Billie Eilish — Irish acts Aaron Rowe and Beoga, and Lukas Graham of Denmark all post
'Widow's Bay,' 'The Pitt' win big at Emmy Awards (opens the original)
Read excerpt
LOS ANGELES, United States — Quirky horror series "Widow's Bay" cleaned up at the Emmys, setting a new record for the most awards won by a comedy in a single year, as gritty hospital show "The Pitt" won again for best drama. Apple TV's "Widow's Bay," which stars Matthew Rhys as the leader of an isolated New England island that appears to be haunted, emerged as one of the most talked-about debut series of the year, and now has the trophies to back up the buzz. With 14 total awards, "Widow's Bay"
What's the deal with peptides? The hyped market under US review (opens the original)
Read excerpt
Such are the enticing promises of peptides, an increasingly buzzy class of substances touted by influencers and celebrities as the key to an optimized life. Starting Thursday, a US review panel convened by the Food and Drug Administration is to consider whether seven of these peptides should be recommended for compounding — when pharmacists or outsourcing facilities create custom drugs — as interest in them surges. Many medical experts have warned against that recommendation, citing a lack of ev
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Philstar, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.